Smart Asthma Monitoring Device Market Size

  • Report ID: 3918
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Smart Asthma Monitoring Device Market Size

Smart Asthma Monitoring Device Market size was over USD 1.47 billion in 2024 and is projected to reach USD 25.65 billion by 2037, witnessing around 24.6% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of smart asthma monitoring device is assessed at USD 2.11 billion.

The market is predicted to grow with the escalating incorporation of smart inhalers. Smart inhalers are developing as one of the most significant areas of pharmaceutical engagement in digital health. In order to improve the management of asthma and enhance the effectiveness of medication key market players are promoting the use of smart inhalers this is expected to boost the market in the projected period.

Besides, significant market players all across the globe are highly investing in the development of monitoring devices for the enhanced treatment of asthma. One of the key factors driving the growth of the smart asthma monitoring devices sector is the emphasis of these companies on developing products that can help patients and doctors learn more about asthma, improve symptoms and outcomes, and have automated communication for patients and doctors to know what's going on in between visits. In the United States, tens of millions of individuals utilize MDIs. The total quantity of medicine that reaches the lungs can be significantly influenced by techniques like moving the MDI 10-15 times and controlling the sequence and location of breaths. One hundred users of inhalers utilize 90 of them improperly, and 66 forget to take their medication.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3918
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of smart asthma monitoring device is assessed at USD 2.11 billion.

The smart asthma monitoring device market size was over USD 1.47 billion in 2024 and is projected to reach USD 25.65 billion by 2037, witnessing around 24.6% CAGR during the forecast period i.e., between 2025-2037. The growing prevalence of asthma, backed by rapid urbanization will drive the market growth.

North America industry is likely to hold largest revenue share of 38% by 2037, driven by high incidence of asthma in developed nations.

The major players in the market are Astellas Pharma Inc., Adherium Limited, AstraZeneca Group, Cohero Health, Inc., GlaxoSmithKline plc, Aevice Health, Vectura Group plc, BioTelemetry, Inc., Health Care Originals Inc., Reciprocal Labs Corporation
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample